BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Leaders in Breast and Lung Cancer treatment join SystImmune Inc’s Clinical Science Advisory Committee

  SystImmune Inc. has announced the creation of its Clinical Science Advisory Committee, appointing Dr. Hope Rugo, M.D., Dr. Sara Tolaney, M.D., M.P.H, Dr. Pasi Jänne, M.D., Ph.D., MMSC.

  April 26, 2023

   · 

  7 min read
• Pharm Country

  Ocugen, Inc. to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

  Ocugen, Inc. announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on May 2, 2023, at the Nasdaq Market Site in Times Square, New York City.

  April 26, 2023

   · 

  2 min read
• Business

  Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023

  Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern.

  April 26, 2023

   · 

  1 min read
• Business

  Alkermes plc Reports First Quarter 2023 Financial Results

  Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2023.

  April 26, 2023

   · 

  15 min read
• Business

  GlycoMimetics to Report First Quarter 2023 Financial Results on May 3, 2023

  GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2023 financial results on Wednesday, May 3, 2023, at 8:30 a.m. ET.

  April 26, 2023

   · 

  1 min read
• Drug Development

  AlloVir Announces Positive Results Including Long-Term Mortality Data in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at EBMT 2023

  AlloVir, Inc. today announced the presentation of positive long-term, follow-up data from the Phase 2 study of posoleucel for the prevention of clinically significant infections from six common and devastating viruses in allogeneic hematopoietic cell transplant (allo-HCT) recipients.

  April 26, 2023

   · 

  8 min read
• Pharm Country

  MindMed to Participate in May Investor Conferences

  Mind Medicine announced today that members of the Company’s management team will participate in the following investor conferences.

  April 26, 2023

   · 

  1 min read
• Business

  Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

  Surmodics, Inc. today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023.

  April 26, 2023

   · 

  22 min read
• Drug Development

  Uvax Bio Announces Publication of Results from Preclinical Studies of HIV Vaccine Candidates

  Uvax Bio , LLC today announced that its HIV vaccine candidates have shown significant improvement in immune response compared with current vaccine strategies.

  April 26, 2023

   · 

  3 min read
• Business

  Evelo Biosciences Provides Clinical Updates

  Evelo Biosciences, Inc. today announced updates to its clinical programs.

  April 26, 2023

   · 

  9 min read